Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rangering i aksjer
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aksjekurs
$3.89
Markedsverdi
$3.30B
Endring (1 dag)
-3.14%
Endring (1 år)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Kategori
Healthcare
Antall utestående aksjer for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Antall utestående aksjer per June 2026: 849.93M
Ifølge Guangdong Zhongsheng Pharmaceutical Co., Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 849.93M. Ved slutten av December 2024 hadde selskapet 830.99M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317) fra 2006 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 849.93M | 1.71% |
| 2025 | 835.62M | 0.56% |
| 2024 | 830.99M | 1.00% |
| 2023 | 822.73M | 2.19% |
| 2022 | 805.13M | 0.97% |
| 2021 | 797.43M | -0.74% |
| 2020 | 803.36M | 0.00% |
| 2019 | 803.36M | -0.42% |
| 2018 | 806.76M | -0.14% |
| 2017 | 807.93M | 7.24% |
| 2016 | 753.40M | 4.10% |
| 2015 | 723.69M | -0.10% |
| 2014 | 724.39M | 0.34% |
| 2013 | 721.93M | -0.57% |
| 2012 | 726.05M | 1.28% |
| 2011 | 716.85M | -0.52% |
| 2010 | 720.60M | 34.04% |
| 2009 | 537.61M | -0.42% |
| 2008 | 539.88M | -0.65% |
| 2007 | 543.42M | 0.00% |
| 2006 | 543.42M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 434.78M | -48.85% |
DE
|
|
| 434.78M | -48.85% |
DE
|
|
| 1.56B | 83.85% |
JP
|
|
| 233.66M | -72.51% |
CH
|
|
| 2.40B | 182.30% |
IN
|
